michael23 Posted - 1 week ago

$KRYS Imagine if they got a price decrease ha

Nigela Posted - 1 week ago

Los Angeles Capital Management LLC Sells 100 Shares of Krystal Biotech, Inc. ( $KRYS) 141,996 Shares in Gladstone Commercial Co. ( $GOOD) Purchased by Los Angeles Capital Management LLC Wimi Hologram Cloud Inc. ( $WIMI ) Shares Bought by Cornerstone Planning Group

Ortho91 Posted - 1 week ago

$KRYS what a great Friday here !!!!!

rubraquercus Posted - 1 week ago

$KRYS Thank you for leaving kirkiefuk at $PGEN

stephanjk59 Posted - 1 week ago

$KRYS New highs only a matter of time. Takeover candidate.

Ortho91 Posted - 2 weeks ago

$KRYS 🙌🙌🙌

FlynancialAnalyst Posted - 2 weeks ago

@Doozio $KRYS back to ATHs

Doozio Posted - 2 weeks ago

$KRYS they maybe CHSN bahht its still early INTA 🧠⏰♾️

DonCorleone77 Posted - 2 weeks ago

$KRYS Krystal Biotech price target raised to $212 from $208 at Chardan Chardan raised the firm's price target on Krystal Biotech to $212 from $208 and keeps a Buy rating on the shares post the Q3 report. The firm says the Vyjuvek launch remains strong.

Doozio Posted - 2 weeks ago

$KRYS MNDY 🐑 🎁 INTA 🧠⏰♾️

seet79 Posted - 2 weeks ago

$krys Bought more, one of the best out here

ZManicItalian Posted - 2 weeks ago

$KRYS ex-US sales gets going next year 💪

seet79 Posted - 2 weeks ago

$KRYS decent ER?

kenny91655 Posted - 10/30/24

$KRYS Going over the last earnings call and the last conference, they will include the last 12.5 settlement claim 3rd quarter. Watch for reaction before bell to perceived miss.

Quantumup Posted - 10/27/24

BofA $IMTX, $NTLA, $JANX, $KRYS, $NVAX

Doozio Posted - 10/24/24

$krys so on FRYday?

Quantumup Posted - 1 month ago

BofA 3Q24 SMID #Biotech earnings preview: $DAWN $SWTX CRSP in focus: $DAWN (Buy/$24): Ojemda launch, pivotal trial focus: $SWTX (Buy/$58): Ogsiveo should recover after soft early Q3: Additional Commercial-Stage Companies Also Mentioned NVAX, $KRYS, $TGTX, AGIO, and $YMAB

WeeklyTrader Posted - 1 month ago

The stars are aligning for $KRYS! RSI: 47.31% 50-day MA: $186.46 200-day MA: $167.04

Doozio Posted - 1 month ago

$KRYS 3wt bahhhtom of da base as da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️

WeeklyTrader Posted - 1 month ago

Let’s spill the tea on $KRYS's struggles! RSI: 46.06% 50-day MA: $186.71 200-day MA: $166.78

seet79 Posted - 1 month ago

$KRYS this correction is a lot for this multi year winner- should assume uptrend any day now

WeeklyTrader Posted - 1 month ago

The end of the line for $KRYS!

50bps Posted - 1 month ago

$KRYS hmm. what u waiting for?

Night_Owl_Biotech Posted - 1 month ago

The attachment compares $VRNA analyst consensus revenue estimates to actual revenue estimates prepared by the acquiree in 10 recent commercial-stage non-oncology focused M&A transactions as reported in subsequent 14D9 filings. It has been almost 4 months since Ensifentrine's approval. We have no idea if VRNA will ever be acquired. However, RETA was acquired 5 months after Omaveloxolone's approval. CCXI & VIE were acquired within 8-10 months of their FDA approval. If you believe M&A valuations are based on anticipated revenues then one could compare enterprise values paid (not market caps) as multiples of cumulative projected revenues. Recent (past 2 years) new commercial stage non-oncology focused bios include $TARS $MDGL $KRYS & $AXSM As always, we may make inadvertent mistakes and/or typos compiling data. This is not investment advice.

Pfreakstocks Posted - 1 month ago

$KRYS @cubie AH glitch? I don’t see that price jump in RH

Jumpman23 Posted - 1 month ago

$KRYS $200

Hbogati Posted - 09/27/24

$KRYS What is the contrarian thesis here, why isnt this valued more?

classhopper Posted - 09/25/24

$KRYS still sayin UNDERVALUED here

seet79 Posted - 09/24/24

$KRYS stock dropped almost 40 bucks within weeks

classhopper Posted - 2 months ago

$KRYS will be UP $10 tomorrow